Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference101 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. Epithelial ovarian cancer;Lheureux;Lancet (London, England),2019
3. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance;Ediriweera;Semin Cancer Biol,2019
4. Targeting PI3K in cancer: mechanisms and advances in clinical trials;Yang;Mol Cancer,2019
5. Latest clinical evidence and further development of PARP inhibitors in ovarian cancer;Mirza;Ann Oncol,2018
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. drexml: A command line tool and Python package for drug repurposing;Computational and Structural Biotechnology Journal;2024-12
2. Melatonin changes energy metabolism and reduces oncogenic signaling in ovarian cancer cells;Molecular and Cellular Endocrinology;2024-10
3. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment;Clinical and Translational Medicine;2024-08-29
4. Melatonin regulates endoplasmic reticulum stress in diverse pathophysiological contexts: A comprehensive mechanistic review;Journal of Cellular Physiology;2024-07-22
5. Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling;Epigenomics;2024-07-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3